The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

scientific article published on 18 March 2015

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00345-015-1531-6
P698PubMed publication ID25782867

P50authorShahrokh ShariatQ7462263
P2093author name stringMarianne Schmid
Margit Fisch
Luis A Kluth
Armin Soave
Michael Rink
Oliver Engel
Roland Dahlem
Sven Peine
P2860cites workCancer statistics, 2014Q27861018
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortiumQ34094983
AB0 blood group and prognosis in patients with pancreatic cancerQ34354138
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counsellingQ36419132
The Rh protein family: gene evolution, membrane biology, and disease associationQ37642606
ABO blood group and cancerQ37787521
Biomolecular predictors of urothelial cancer behavior and treatment outcomesQ37987066
ABO blood group: old dogma, new perspectivesQ38104553
Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transitionQ38203883
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference CommitteeQ40831782
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomyQ43622475
ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancerQ43879790
Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.Q45904406
Predictors of cancer-specific mortality after disease recurrence following radical cystectomyQ46489162
Do blood groups have effect on prognosis of patients undergoing radical cystectomy?Q51150690
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.Q52839590
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.Q54391399
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.Q54448028
Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.Q54729569
Barrettʼs, blood groups and progression to oesophageal cancerQ59342685
Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinomaQ68053765
Rhesus D-phenotype does not provide prognostic information additional to TNM staging in gastric cancer patientsQ73847753
Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancerQ74320800
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinomaQ83192683
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patientsQ84072813
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinomaQ84947425
Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomyQ87230245
P433issue11
P921main subjectRadical cystectomyQ111329312
P304page(s)1769-1776
P577publication date2015-03-18
P1433published inWorld Journal of UrologyQ15750774
P1476titleThe impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
P478volume33

Reverse relations

cites work (P2860)
Q53175926AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.
Q64966406ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.
Q49380161Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
Q28551903Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer
Q41432872The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
Q48007072The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
Q49407223The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients
Q53185271Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.